A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence

by Shivani Kamdar, Neil E. Fleshner, Bharati Bapat
Published 2020-10-01

Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma

by Madonna R. Peter, Madonna R. Peter, Fang Zhao, Fang Zhao, Renu Jeyapala, Renu Jeyapala, Shivani Kamdar, Shivani Kamdar, Wei Xu, Cynthia Hawkins, Cynthia Hawkins, Andrew J. Evans, Neil E. Fleshner, Antonio Finelli, Bharati Bapat, Bharati Bapat
Published 2022-01-01

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

by Shivani Kamdar, Ruth Isserlin, Theodorus Van der Kwast, Alexandre R. Zlotta, Gary D. Bader, Neil E. Fleshner, Bharati Bapat
Published 2019-03-01

A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer

by Fang Zhao, Ekaterina Olkhov-Mitsel, Shivani Kamdar, Renu Jeyapala, Julia Garcia, Rachel Hurst, Marcelino Yazbek Hanna, Robert Mills, Alexandra V. Tuzova, Eve O’Reilly, Sarah Kelly, Colin Cooper, The Movember Urine Biomarker Consortium, Daniel Brewer, Antoinette S. Perry, Jeremy Clark, Neil Fleshner, Bharati Bapat
Published 2018-11-01